M J During|C G Janson - JoVE Visualize

Showing results (71-80 of 85) with videos related to

Pageof 9

Sort By:

Pediatric Research|May 1, 1996

Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheepW K Tan, C E Williams, M J During, et al.

Gene Therapy|September 19, 2014

Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsyD Young, D M Fong, P A Lawlor, et al.

Gene Therapy|February 13, 2004

Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behaviorA J Noordmans, D K Song, C J Noordmans, et al.

Experimental Neurology|December 17, 1997

Adenovirus vector-mediated gene transfer into human epileptogenic brain slices: prospects for gene therapy in epilepsyW M O'Connor, B L Davidson, M G Kaplitt, et al.

Brain Research. Molecular Brain Research|April 29, 2005

Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan diseaseS W J McPhee, J Francis, C G Janson, et al.

Neuroscience|December 18, 2007

Activity-dependent secretion of neuronal activity regulated pentraxin from vasopressin neurons into the systemic circulationI M Reti, M Miskimon, M Dickson, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001

FHIT gene therapy prevents tumor development in Fhit-deficient miceK R Dumon, H Ishii, L Y Fong, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001

Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry miceS C Jung, I P Han, A Limaye, et al.

Neuropediatrics|December 21, 2006

Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRIC G Janson, S W J McPhee, J Francis, et al.

Science (New York, N.Y.)|February 26, 2000

An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsyM J During, C W Symes, P A Lawlor, et al.

Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:

Pageof 9

Pediatric Research|May 1, 1996

Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheepW K Tan, C E Williams, M J During, et al.

Gene Therapy|September 19, 2014

Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsyD Young, D M Fong, P A Lawlor, et al.

Gene Therapy|February 13, 2004

Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behaviorA J Noordmans, D K Song, C J Noordmans, et al.

Experimental Neurology|December 17, 1997

Adenovirus vector-mediated gene transfer into human epileptogenic brain slices: prospects for gene therapy in epilepsyW M O'Connor, B L Davidson, M G Kaplitt, et al.

Brain Research. Molecular Brain Research|April 29, 2005

Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan diseaseS W J McPhee, J Francis, C G Janson, et al.

Neuroscience|December 18, 2007

Activity-dependent secretion of neuronal activity regulated pentraxin from vasopressin neurons into the systemic circulationI M Reti, M Miskimon, M Dickson, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001

FHIT gene therapy prevents tumor development in Fhit-deficient miceK R Dumon, H Ishii, L Y Fong, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001

Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry miceS C Jung, I P Han, A Limaye, et al.

Neuropediatrics|December 21, 2006

Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRIC G Janson, S W J McPhee, J Francis, et al.

Science (New York, N.Y.)|February 26, 2000

An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsyM J During, C W Symes, P A Lawlor, et al.

Pageof 9